Q4 2025 Earnings Call February 24, 2026 7:01 PM ESTCompany ParticipantsRyan Kolln - CEO, MD & DirectorJustin Miles - ...
Arcus Biosciences (NYSE:RCUS) used its fourth-quarter and full-year 2025 earnings call to highlight updated clinical data for its lead oncology program, casdatifan, and to outline near-term plans for ...
The cost of healthcare in the United States is on the rise in a big way. In its 2026 healthcare outlook, the Big Four accounting firm PricewaterhouseCoopers (PwC) made strong statements confirming ...
Annual Neudata report estimates 2025 spend rose 17% to $2.8bn, finds firms are using AI mainly for productivity vs investment optimisation, and highlights less "crowding" on average per dataset.LONDON ...
Rail Vision Ltd. (Nasdaq: RVSN) ("Rail Vision" or the "Company"), an early commercialization stage technology company focused on transforming railway ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results